150 likes | 436 Views
Audit of Adherence to RAH Policy on Pre-Operative Cardiovascular and Oral Hypoglycaemics Medication in Elective Theatre Patients. Sam Ley & Eilidh McGinnigle. OUTLINE. Summary of pre-operative routine medication policy Our Question Method Results Conclusion & discussion
E N D
Audit of Adherence to RAH Policy on Pre-Operative Cardiovascular and Oral Hypoglycaemics Medication in Elective Theatre Patients Sam Ley & EilidhMcGinnigle
OUTLINE • Summary of pre-operative routine medication policy • Our Question • Method • Results • Conclusion & discussion • Limitations & future plans • Your Questions
POLICY SUMMARY Continue everything except: • Hypoglycaemic agents in fasting patients • Adjust insulin regimens • Stop MAOIs Advance decisions required for: • Anticoagulants/antiplatelets • Lithium • HRT/COCP
QUESTION Do elective patients admitted before the day of surgery comply with the RAH preoperative medication policy regarding cardiovascular and oral hypoglycaemic agents?
STUDY POPULATION • Admitted before day of surgery • Oral hypoglyaemics • Any CV medication excluding antiplatelet/anticoagulants • Elective hip/knee replacement • Elective cystoscopic procedures • Elective laparotomy
METHOD • Audit over 5 weeks • Age/procedure/co-morbidity • Class of drug • Deviations • Reasons • Adverse Events
CONCLUSION Do elective patients admitted before the day of surgery comply with the RAH preoperative medication policy regarding cardiovascular and oral hypoglycaemic agents? (YES)
LIMITATIONS • Missing data • Relatively small data set • Elective cases only • No general surgical patients
INCIDENTAL OBSERVATIONS • Protocol only displayed on Ward 26 • Ward medical staff unaware of it • Nurses are fully aware • Conflicts with ENHANCED RECOVERY PROTOCOL • No mention of new hypoglycaemic agents
ENHANCED RECOVERY PROTOCOL • Developed at GJNH by elective ortho team • Premedication • Routine medication • Anaesthetic technique • Peri-operative analgesia REFERENCE: McDonald DA et al, An enhanced recovery programme for primary total knee arthroplasty in the UK-followup atone year, Knee (2011), doi: 10.1016/j.knee.2011.07.012
POINTS FOR DISCUSSION • New hypoglycaemic medications • Stents and antiplatelet therapy • ERP
FUTURE PLANS • ?Review of protocol • FY1 teaching session • Re-audit?